156 related articles for article (PubMed ID: 2798746)
1. An evaluation of measles, mumps and rubella vaccine in a population of Yorkshire infants.
Dunlop JM; RaiChoudhury K; Roberts JS; Bryett KA
Public Health; 1989 Sep; 103(5):331-5. PubMed ID: 2798746
[TBL] [Abstract][Full Text] [Related]
2. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
[TBL] [Abstract][Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
4. Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine.
Berger R; Just M
J Biol Stand; 1988 Oct; 16(4):275-9. PubMed ID: 2848843
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to measles, mumps and rubella in UK children 4 years after vaccination with different MMR vaccines.
Miller E; Hill A; Morgan-Capner P; Forsey T; Rush M
Vaccine; 1995 Jun; 13(9):799-802. PubMed ID: 7483800
[TBL] [Abstract][Full Text] [Related]
6. A second dose of MMR vaccine for children in the United Kingdom.
Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
[No Abstract] [Full Text] [Related]
7. Reactogenicity and immunogenicity of a new live attenuated combined measles, mumps and rubella vaccine in healthy children.
Usonis V; Bakasenas V; Kaufhold A; Chitour K; Clemens R
Pediatr Infect Dis J; 1999 Jan; 18(1):42-8. PubMed ID: 9951979
[TBL] [Abstract][Full Text] [Related]
8. Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination.
King GE; Markowitz LE; Heath J; Redd SC; Coleman S; Bellini WJ; Sievert A
JAMA; 1996 Mar; 275(9):704-7. PubMed ID: 8594268
[TBL] [Abstract][Full Text] [Related]
9. A randomised single blind trial of a combined mumps measles rubella vaccine to evaluate serological response and reactions in the UK population.
Edees S; Pullan CR; Hull D
Public Health; 1991 Mar; 105(2):91-7. PubMed ID: 2068243
[TBL] [Abstract][Full Text] [Related]
10. Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age.
Klinge J; Lugauer S; Korn K; Heininger U; Stehr K
Vaccine; 2000 Jul; 18(27):3134-40. PubMed ID: 10856793
[TBL] [Abstract][Full Text] [Related]
11. Serologic responses to measles, mumps, and rubella (MMR) vaccine in healthy infants: failure to respond to measles and mumps components may influence decisions on timing of the second dose of MMR.
Mitchell LA; Tingle AJ; Décarie D; Lajeunesse C
Can J Public Health; 1998; 89(5):325-8. PubMed ID: 9813922
[TBL] [Abstract][Full Text] [Related]
12. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Findings in clinical and laboratory studies.
Makino S; Sasaki K; Nakayama T; Oka S; Urano T; Kimura M; Kawana R; Yamamura AM
Am J Dis Child; 1990 Aug; 144(8):905-10. PubMed ID: 2198807
[TBL] [Abstract][Full Text] [Related]
13. Interference between strains in live virus vaccines, I: Combined vaccination with measles, mumps and rubella vaccine.
Berger R; Just M; Glück R
J Biol Stand; 1988 Oct; 16(4):269-73. PubMed ID: 3198657
[TBL] [Abstract][Full Text] [Related]
14. Serological evaluation of a measles, mumps, and rubella vaccine.
Robertson CM; Bennett VJ; Jefferson N; Mayon-White RT
Arch Dis Child; 1988 Jun; 63(6):612-6. PubMed ID: 3291787
[TBL] [Abstract][Full Text] [Related]
15. Reactogenicity and immunogenicity of a new combined measles-mumps-rubella vaccine: results of a multicentre trial. The Cooperative Group for the Study of MMR vaccines.
Crovari P; Gabutti G; Giammanco G; Dentico P; Moiraghi AR; Ponzio F; Soncini R
Vaccine; 2000 Jun; 18(25):2796-803. PubMed ID: 10812221
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.
Vesikari T; Ohrling A; Baer M; Delem A; Bogaerts H; André FE
Acta Paediatr Scand; 1991 Nov; 80(11):1051-7. PubMed ID: 1661057
[TBL] [Abstract][Full Text] [Related]
17. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
18. [Immunity to measles, mumps and rubella in children vaccinated with triple viral vaccine].
Pisón Garcés FJ; Galbe Sánchez-Ventura J; Arcauz Eguren P; Aguirre y Dabán C; Mengual Gil J; Larrad Mur L
Aten Primaria; 1995 Mar; 15(4):235-7. PubMed ID: 7703334
[TBL] [Abstract][Full Text] [Related]
19. Changes of the immunological patterns against measles, mumps and rubella. A vaccination programme studied 3 to 7 years after the introduction of a two-dose schedule.
Christenson B; Böttiger M
Vaccine; 1991 May; 9(5):326-9. PubMed ID: 1872016
[TBL] [Abstract][Full Text] [Related]
20. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
Takayama N; Kidokoro M; Suzuki K; Morita M
Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
